GR3003232T3 - Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient - Google Patents

Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient

Info

Publication number
GR3003232T3
GR3003232T3 GR91401837T GR910401837T GR3003232T3 GR 3003232 T3 GR3003232 T3 GR 3003232T3 GR 91401837 T GR91401837 T GR 91401837T GR 910401837 T GR910401837 T GR 910401837T GR 3003232 T3 GR3003232 T3 GR 3003232T3
Authority
GR
Greece
Prior art keywords
processes
production
active ingredient
quinazoline derivative
cerebral dysfunction
Prior art date
Application number
GR91401837T
Other languages
English (en)
Inventor
Ryuichi Iemura
Manabu Hori
Hiroshi Ohtaka
Takayuki Sukamoto
Hideaki Hara
Keizo Ito
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of GR3003232T3 publication Critical patent/GR3003232T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR91401837T 1987-08-10 1991-11-28 Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient GR3003232T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62200510A JPS6442472A (en) 1987-08-10 1987-08-10 Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient

Publications (1)

Publication Number Publication Date
GR3003232T3 true GR3003232T3 (en) 1993-02-17

Family

ID=16425510

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401837T GR3003232T3 (en) 1987-08-10 1991-11-28 Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient

Country Status (6)

Country Link
EP (1) EP0302967B1 (el)
JP (1) JPS6442472A (el)
AT (1) ATE69049T1 (el)
DE (1) DE3774273D1 (el)
ES (1) ES2044908T3 (el)
GR (1) GR3003232T3 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041443A (en) * 1989-02-21 1991-08-20 Dainippon Pharmaceutical Co., Ltd. Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
US5185338A (en) * 1989-02-21 1993-02-09 Dainippon Pharmaceutical Co., Ltd. Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US7019012B2 (en) 2000-12-20 2006-03-28 Boehringer Ingelheim International Pharma Gmbh & Co. Kg Quinazoline derivatives and pharmaceutical compositions containing them
TW200424188A (en) 2002-10-01 2004-11-16 Mitsubishi Pharma Corp Isoquinoline compound and pharmaceutical use thereof
DE10349113A1 (de) 2003-10-17 2005-05-12 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aminocrotonylverbindungen
CA2833706C (en) 2005-11-11 2014-10-21 Boehringer Ingelheim International Gmbh Quinazoline derivatives for the treatment of cancer diseases
EP2068880B1 (en) 2006-09-18 2012-04-11 Boehringer Ingelheim International GmbH Method for treating cancer harboring egfr mutations
HRP20191005T1 (hr) 2009-07-06 2019-08-23 Boehringer Ingelheim International Gmbh Postupak sušenja bibw2992, njegovih soli i čvrstih farmaceutskih formulacija koje sadrže taj djelatni sastojak
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
DE102015012049A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives

Also Published As

Publication number Publication date
EP0302967A2 (en) 1989-02-15
EP0302967A3 (en) 1989-05-03
ATE69049T1 (de) 1991-11-15
ES2044908T3 (es) 1994-01-16
JPS6442472A (en) 1989-02-14
DE3774273D1 (de) 1991-12-05
EP0302967B1 (en) 1991-10-30

Similar Documents

Publication Publication Date Title
GR3034507T3 (en) Pyrazolopyrimidines as crf antagonists.
NO950297D0 (no) Prolinamidderivater
AU616838B2 (en) N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro- 2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives
FI933391A0 (fi) Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning
CA2124455A1 (en) Indole derivatives, process for producing the same and medicinal uses of the same
PT83104A (en) Novel guanidinomethylbenzoic acid derivatives
GR3003232T3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
PT90034A (pt) Processo para a preparacao de tetra-hidroimidazo-{1,4}benzodiazepina-2-onas
GR3005990T3 (el)
EP0314098A3 (en) Imide derivatives, their production and use
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
ZA858659B (en) Use of spergualin derivatives for the preparation of medicaments having immunosuppressive activity
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
GB1470747A (en) Pyridazine derivative
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
CA1270833C (en) 2,5-PYRROLIDINEDIONE DERIVATIVES USEFUL AS ANTI-ARHYTMIZING AGENTS